Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells

Clock genes: Their role in colorectal cancer

(2014) Theodoros Karantanos   WORLD JOURNAL OF GASTROENTEROLOGY

Circadian molecular clocks and cancer

(2013) Fergal C. Kelleher et al.   CANCER LETTERS

Osteosarcoma treatment – Where do we stand? A state of the art review

(2013) Anja Luetke et al.   CANCER TREATMENT REVIEWS

New molecular insights into osteosarcoma targeted therapy

(2013) Jilong Yang et al.   CURRENT OPINION IN ONCOLOGY

Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?

(2013) Norio Yamamoto et al.   EXPERT OPINION ON PHARMACOTHERAPY

Circadian clocks and tumor biology: What is to learn from human skin biopsies?

(2013) Zsuzsanna Lengyel et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue

(2013) Mária Štorcelová et al.   MOLECULAR BIOLOGY REPORTS

Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia

(2013) Sobia Rana et al.   MOLECULAR BIOLOGY REPORTS

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer

(2013) Hongyan Yu et al.   PLoS One

Molecular architecture of the mammalian circadian clock

(2013) Carrie L. Partch et al.   TRENDS IN CELL BIOLOGY

Circadian rhythms and tumor growth

(2012) Michael W. Greene   CANCER LETTERS

Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer

(2012) Daniel Relles et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Physiological and pathophysiological role of the circadian clock system

(2012) Tamás Halmos et al.   ORVOSI HETILAP

Expression of Circadian Per1 and Per2 Genes in the Liver and Breast Tumor Tissues of HER2/neu Transgenic Mice of Different Age

(2011) S. N. Kolomeichuk et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

The circadian mutation PER2 S662G is linked to cell cycle progression and tumorigenesis

(2011) X Gu et al.   CELL DEATH AND DIFFERENTIATION

Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients

(2011) G. Mazzoccoli et al.   CHRONOBIOLOGY INTERNATIONAL

CLOCK in Breast Tumorigenesis: Genetic, Epigenetic, and Transcriptional Profiling Analyses

(2010) A. E. Hoffman et al.   CANCER RESEARCH

Tumor growth suppressionin vivoby overexpression of the circadian component, PER2

(2010) Koyomi Miyazaki et al.   GENES TO CELLS

Circadian variation in the circulatory responses to exercise: relevance to the morning peaks in strokes and cardiac events

(2009) Greg Atkinson et al.   EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY

Circadian Time-Dependent Tumor Suppressor Function of Period Genes

(2009) Xiaoming Yang et al.   INTEGRATIVE CANCER THERAPIES

The regulation of central and peripheral circadian clocks in humans

(2009) N. Cermakian et al.   Obesity Reviews

Per2 Inhibits K562 Leukemia Cell Growth In Vitro and In Vivo Through Cell Cycle Arrest and Apoptosis Induction

(2009) Cheng-ming Sun et al.   PATHOLOGY & ONCOLOGY RESEARCH

A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway

(2009) Jasper Mullenders et al.   PLoS One

Disturbance of circadian gene expression in hepatocellular carcinoma

(2008) Yueh-Min Lin et al.   MOLECULAR CARCINOGENESIS